Skip to Content

  • Search

View Additional Section Content

TRACER - A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficiency of SCH 530348 in addition to standard of care in subjects with acute coronary syndrome: Thrombin Receptor Antagonist for clinical Event Reduction in acute coronary syndrome.

Principal Investigator(s)
John H. Wertheimer, M.D.
Patrick Aquilina, M.D. (Sub-Investigator)
Bruce D. Klugherz, M.D. (Sub-Investigator)
Andrew S. Fireman, M.D. (Sub-Investigator)
Robert A. Watson, III, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Cardiology
Beth Bishop at 215-517-1027


  • Abington Medical Specialists

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details